FWBCX | RCWCX | FWBCX / RCWCX | |
Total Expense Ratio | 0.54 | 1.13 | 48% |
Annual Report Gross Expense Ratio | 0.54 | 1.13 | 48% |
Fund Existence | 5 years | 23 years | - |
Gain YTD | 6.686 | 6.361 | 105% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 9.9B | 9.9B | 100% |
Annual Yield % from dividends | 3.53 | 2.92 | 121% |
Returns for 1 year | 6.66 | 6.12 | 109% |
Returns for 3 years | 10.20 | 7.38 | 138% |
Returns for 5 years | N/A | -11.63 | - |
Returns for 10 years | N/A | 0.23 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BKLSX | 9.70 | -0.08 | -0.82% |
BlackRock U.S. Insights Long/Shrt Eq K | |||
LAFTX | 19.35 | -0.19 | -0.97% |
Lord Abbett Affiliated R5 | |||
HIEMX | 8.11 | -0.10 | -1.22% |
Virtus SGA Emerging Markets Equity I | |||
MVISX | 42.37 | -0.75 | -1.74% |
Patient Opportunity IS | |||
WPGSX | 10.10 | -0.19 | -1.85% |
WPG Partners Select Small Cap Value Ins |